GLP-1 Newsroom is your go-to source for breaking news, expert updates, trends, products, and real-world insights on everything related to GLP-1 medications, journeys, and diets.
You’ve probably heard the term metabolic syndrome tossed around lately—on wellness podcasts, in doctors’ offices, even on TikTok. It sounds serious (it is), but also vague (it kind of is). Is it diabetes? A slow metabolism? Is it just another name for being overweight? Not exactly.
In this article, we'll explore what metabolic syndrome is, its risk factors
Tirzepatide is one of the newest GLP-1-based medications to get FDA approval, and it’s changing the conversation around weight loss and metabolic health in a big way. While tirzepatide for weight loss is a big lure, it's also used to treat Type 2 Diabetes and Obstructive Sleep Apnea (OSA).
If you’ve heard someone mention Ozempic or Wegovy recently, you’ve already heard of semaglutide—just not by its chemical name. Semaglutide is a medication that has changed the game in two major areas: managing type 2 diabetes and helping people lose weight.
